Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Gross Profit (2016 - 2025)

Fortress Biotech (FBIO) has 11 years of Gross Profit data on record, last reported at $11.3 million in Q3 2025.

  • For Q3 2025, Gross Profit rose 20.61% year-over-year to $11.3 million; the TTM value through Sep 2025 reached -$14.6 million, up 11.89%, while the annual FY2024 figure was -$19.4 million, 9.71% down from the prior year.
  • Gross Profit reached $11.3 million in Q3 2025 per FBIO's latest filing, down from $11.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $12.6 million in Q1 2022 and bottomed at -$45.7 million in Q4 2024.
  • Average Gross Profit over 5 years is $2.8 million, with a median of $8.8 million recorded in 2022.
  • The widest YoY moves for Gross Profit: up 236.32% in 2023, down 584.84% in 2023.
  • A 5-year view of Gross Profit shows it stood at $8.8 million in 2021, then decreased by 0.74% to $8.7 million in 2022, then crashed by 584.84% to -$42.1 million in 2023, then dropped by 8.5% to -$45.7 million in 2024, then skyrocketed by 124.66% to $11.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $11.3 million in Q3 2025, $11.5 million in Q2 2025, and $8.3 million in Q1 2025.